共 61 条
[1]
Goedhals L(1998)Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: a double-blind, placebo-controlled, comparative study Ann Oncol 9 661-666
[2]
Heron JF(1998)Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 16 1174-1178
[3]
Kleisbauer JP(2000)Dexamethasone alone or in combination with ondansetron for prevention of delayed nausea and vomiting induced by chemotherapy N Engl J Med 342 1554-1559
[4]
Latreille J(2005)Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 h after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications J Clin Oncol 23 1289-1294
[5]
Pater J(1995)The interaction of RS25259-197, a potent and antagonist, with 5-HT3 receptors, in vitro Br J Pharmacol 114 851-859
[6]
Johnston D(2009)A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy Ann Oncol 20 1860-1866
[7]
Geling O(2008)Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor Anesth Analg 107 469-478
[8]
Eichler HG(2010)Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function Eur J Pharmacol 626 193-199
[9]
Wong EH(2009)Palonosetron plus dexamethasone versus granisetoron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind double-dummy randomised comparative phase III trial Lancet Oncol 10 115-124
[10]
Clark R(2012)A guideline for antimetics use for patients with malignancies Gan To Kagaku Ryoho 39 1163-1168